1
To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames
Condition(s):Lymphoma LeukemiaLast Updated:June 5, 2019Not yet recruiting
Liposomal Doxorubicin: 2256 Clinical Trials, Page 1 of 226
Hide Studies Not Open or Pending
2
T-DM1 and Non-pegylated Liposomal Doxorubicin in HER2-positive Metastatic Breast Cancer
Condition(s):Breast CancerLast Updated:November 27, 2020Completed
3
A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer
Condition(s):HER-2 Positive Breast Cancer; Malignant Neoplasm of BreastLast Updated:February 2, 2016Terminated
4
Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
Condition(s):SarcomaLast Updated:March 21, 2019Recruiting
5
Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
Condition(s):Sarcoma, KaposiLast Updated:July 24, 2018Completed
6
Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma
Condition(s):Stage III Adult Soft Tissue SarcomaLast Updated:February 21, 2021Recruiting
7
Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer
Condition(s):Neoplasms, OvarianLast Updated:July 21, 2017Completed
8
MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011)
Condition(s):Ovarian CancerLast Updated:October 19, 2016Terminated
9
Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer
Condition(s):Breast CancerLast Updated:July 19, 2017Completed
10
CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER
Condition(s):Breast CancerLast Updated:February 12, 2021Active, not recruiting